Atlas Trials

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Clinical trial NCT04392128 · WITHDRAWN

Trial details

NCT number
NCT04392128
Sponsor
Institut de cancérologie Strasbourg Europe
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID19Hematologic Malignancy
Start date
2020-09-02
Primary completion
2020-09-02
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.